Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 13765 [2022-05047]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 47 / Thursday, March 10, 2022 / Notices
(1) Organization name;
(2) Organization type (e.g., non-profit or
law firm);
(3) Name and title of primary contact;
(4) Primary contact mailing address, phone
number, and email address;
(5) Names and a brief description of
relevant experience of principals and key
staff;
(6) Names and a brief description of
relevant experience of the current governing
board;
(7) Brief description of how your
organization will serve eligible veterans,
dependents, or other persons with
proceedings before the Court regardless of
their location or residence; and
(8) If the non-profit organization has not
yet been established, names and a brief
description of relevant experience of
prospective members of a governing board.
‘‘Relevant experience’’ includes
experience with: (a) Veterans benefits
law; (b) recruiting, training, supervising,
and assigning cases to volunteer
attorneys; (c) practice before the Court
or supervision of attorneys practicing
before the Court; (d) reviewing and
evaluating veterans benefits cases; and
(e) outreach and education for veterans
and dependents regarding veterans
benefits rights and procedures.
The Pre-Application must not exceed
seven (7) single-spaced pages and must
be submitted as a single PDF document.
D. Late or Incomplete Pre-Applications
LSC may consider a request to submit
a Pre-Application after the deadline, but
only if the Applicant submitted an
email to TaboasA@lsc.gov explaining
the circumstances that caused the delay
before the Pre-Application deadline.
Communication with LSC staff is not a
substitute for sending a formal request
and explanation to TaboasA@lsc.gov. At
its discretion, LSC may consider
incomplete Pre-Applications. LSC will
determine the admissibility of late or
incomplete Pre-Application on a caseby-case basis.
khammond on DSKJM1Z7X2PROD with NOTICES
E. Additional Information and
Guidelines
Additional guidance and instructions
on the Veterans Pro Bono Program PreApplication and Application processes
will be available on https://lsc.gov/
grants/veterans-pro-bono-grantprogram.
The Application, guidelines, content
requirements, and specific selection
criteria will be available the week of
May 10, 2022, at www.lsc.gov.
For more information about the
current grantee, The Veterans
Consortium Pro Bono Program, please
visit www.vetsprobono.org.
Authority: 42 U.S.C. 2996g(e).
VerDate Sep<11>2014
16:20 Mar 09, 2022
Jkt 256001
Dated: March 4, 2021.
Stefanie Davis,
Senior Associate General Counsel.
[FR Doc. 2022–05031 Filed 3–9–22; 8:45 am]
BILLING CODE 7050–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on April 5, 2022. A sample of agenda
items to be discussed during the public
session includes: An overview of fiscal
year (FY) 2021 medical related events;
an overview of how to minimize
institutional approaches to reducing
medical events; an overview of two
yttrium-90 microsphere technologies; an
overview on non-medical events for FYs
2020 and 2021; updates on the National
Institute of Standards and Technology
Radioisotope Measurement Assurance
Program; a discussion on the current
ACMUI reporting structure; and an
update on Medical Team activities. The
agenda is subject to change. The current
agenda and any updates will be
available on the ACMUI’s Meetings and
Related Documents web page at https://
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2022.html
or by emailing Mr. Don Lowman at the
contact information below.
Purpose: Discuss issues related to 10
CFR part 35 Medical Use of Byproduct
Material.
Date and Time for Open Session:
Tuesday, April 5, 2022, from 10:00 a.m.
to 5:00 p.m. EST.
SUMMARY:
Date
Webinar information
(Microsoft Teams)
April 5,
2022.
Link: https://teams.microsoft.com/l/
meetup-join/19%3ameeting_
MzgyMWU5ZDUtMD
c2Ny00YmUwLWFkODUtND
k1N2Y5MmEzMTM2%40
thread.v2/0?context=
%7b%22Tid%22%3a%22e8
d01475-c3b5-436a-a065-5def
4c64f52e%22%2c%22Oid%22%
3a%2209a47f07-225c-402e-8b6f
-c9f03adf8db6%22%7d.
Call in number (audio only): +1
301–576–2978 (Silver Spring,
MD, US). Phone Conference ID:
220 765 08#.
PO 00000
Public Participation: The meeting will
be held as a webinar using Microsoft
Teams. Any member of the public who
wishes to participate in any open
sessions of this meeting should click on
the link above to join the meeting. It is
recommended that attendees should
login ten minutes prior to ensure they
can properly connect to the meeting.
Members of the public should also
monitor the NRC’s Public Meeting
Schedule at https://www.nrc.gov/pmns/
mtg for any meeting updates. If there are
any questions regarding the meeting,
persons should contact Mr. Lowman
using the information below.
Contact Information: Mr. Don
Lowman, email: Donald.Lowman@
nrc.gov, telephone: 301–415–5452.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter,
M.D., will preside over the meeting. Dr.
Metter will conduct the meeting in a
manner that will facilitate the orderly
conduct of business. The following
procedures apply to public participation
in the meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Mr. Lowman using
the contact information listed above. All
submittals must be received by the close
of business on March 28, 2022 and must
only pertain to the topics on the agenda.
2. Questions and comments from
members of the public will be permitted
during the meeting, at the discretion of
the ACMUI Chairman.
3. The draft transcript and meeting
summary will be available on ACMUI’s
website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2022.html on or about May 17, 2022.
4. Persons who require special
services, such as those for the hearing
impaired, should notify Mr. Lowman of
their planned participation.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in title 10 of
the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 7th day
of March, 2022.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Federal Advisory Committee Management
Officer.
[FR Doc. 2022–05047 Filed 3–9–22; 8:45 am]
BILLING CODE 7590–01–P
Frm 00079
Fmt 4703
Sfmt 4703
13765
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 87, Number 47 (Thursday, March 10, 2022)]
[Notices]
[Page 13765]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05047]
=======================================================================
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on April 5, 2022. A sample of agenda items to be discussed
during the public session includes: An overview of fiscal year (FY)
2021 medical related events; an overview of how to minimize
institutional approaches to reducing medical events; an overview of two
yttrium-90 microsphere technologies; an overview on non-medical events
for FYs 2020 and 2021; updates on the National Institute of Standards
and Technology Radioisotope Measurement Assurance Program; a discussion
on the current ACMUI reporting structure; and an update on Medical Team
activities. The agenda is subject to change. The current agenda and any
updates will be available on the ACMUI's Meetings and Related Documents
web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2022.html or by emailing Mr. Don Lowman at the contact
information below.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Date and Time for Open Session: Tuesday, April 5, 2022, from 10:00
a.m. to 5:00 p.m. EST.
------------------------------------------------------------------------
Webinar information (Microsoft
Date Teams)
------------------------------------------------------------------------
April 5, 2022.......................... Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_MzgyMWU5ZDUtMDc2Ny00YmUwLWFkODUtNDk1N2Y5MmEzMTM2%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%2209a47f07-225c-402e-8b6f-c9f03adf8db6%22%7d.
Call in number (audio only): +1
301-576-2978 (Silver Spring,
MD, US). Phone Conference ID:
220 765 08#.
------------------------------------------------------------------------
Public Participation: The meeting will be held as a webinar using
Microsoft Teams. Any member of the public who wishes to participate in
any open sessions of this meeting should click on the link above to
join the meeting. It is recommended that attendees should login ten
minutes prior to ensure they can properly connect to the meeting.
Members of the public should also monitor the NRC's Public Meeting
Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. If
there are any questions regarding the meeting, persons should contact
Mr. Lowman using the information below.
Contact Information: Mr. Don Lowman, email: [email protected],
telephone: 301-415-5452.
Conduct of the Meeting
The ACMUI Chair, Darlene F. Metter, M.D., will preside over the
meeting. Dr. Metter will conduct the meeting in a manner that will
facilitate the orderly conduct of business. The following procedures
apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Mr. Lowman using the contact information listed
above. All submittals must be received by the close of business on
March 28, 2022 and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be
permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2022.html on or about May 17, 2022.
4. Persons who require special services, such as those for the
hearing impaired, should notify Mr. Lowman of their planned
participation.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 7th day of March, 2022.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2022-05047 Filed 3-9-22; 8:45 am]
BILLING CODE 7590-01-P
